pharma& Schweiz | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Deals

16 February 2024

The complex web of PARP inhibitor development

GSK’s Zejula win is the latest chapter in a long and convoluted history of PARP inhibition.

Subscribe to pharma& Schweiz